Previous 10 | Next 10 |
ROSELAND, N.J., May 06, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), today announced that its Investigational Device Exemption (IDE) application has been granted full approval by the U.S. Food and Drug Administration (FDA). This approval enables Reno...
RenovaCare ([[RCAR]] +0.4%) says that Alan Rubino has resigned as the company's chairman, CEO and president, effective Mar. 25, 2021. The company has appointed Dr. Kaiyo Nedd to serve as interim president and CEO and Harmel S. Rayat to serve as the chairman, effective...
ROSELAND, N.J., March 30, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of organs and tissues, announced today that its Chairman, Chief Executive Officer, and...
ROSELAND, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), a clinical-stage developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, announced today that the Company...
ROSELAND, N.J., Jan. 19, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), a clinical-stage developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, announced today that the Com...
ROSELAND, N.J., Jan. 08, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), a clinical-stage developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, announced today that the Company...
ROSELAND, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), a clinical-stage developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, announced today that it has issu...
ROSELAND, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced the issuance of two new patents e...
RenovaCare, Inc. (RCAR) Investor Forum Call Oct 29, 2020, 11:00 AM ET Company Participants Alan Rubino - Chairman and CEO Robin Robinson - Chief Scientific Officer Robert Cook - CFO Conference Call Participants Presentation Operator Good morning ladies and gentlemen. Welcome today’s Re...
ROSELAND, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that the Company will begin prese...
News, Short Squeeze, Breakout and More Instantly...
A woman on trial for allegedly laundering billions of dollars of Bitcoin into cash told a London court on Friday that she was the victim of skillfu...
Spark New Zealand Limited ADR (SPKKY) is expected to report for Q1 2024 Taylor Devices Inc. (TAYD) is expected to report for Q1 2024 American Biltrite Inc. (ABLT) is expected to report for quarter end 2023-09-30 Cognetivity Neurosciences Ltd (CGNSF) is expected to report for Q3 2024 ...
1st Cap Bancorp (FISB) is expected to report for Q3 2023 Timberline Resources Corp. (TLRS) is expected to report for Q1 2024 Engie Brasil Energia S.A. ADR (EGIEY) is expected to report for Q4 2023 NuZee Inc. (NUZE) is expected to report for quarter end 2023-09-30 Global Arena Hold...